Navigation Links
Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ESMO Conference

th LHRH analogs and antiandrogens, 21 patients (70%) had failed treatment with steroids and 15 patients (50%) had failed treatment with diethylstilboestrol. Moreover, all of the patients in the study had failed treatment with docetaxel and 10 patients (33%) had failed treatment with an additional cytotoxic agent (mitoxantrone, estramustine, vinorelbine, cyclophosphamide).

Of the 30 patients who have been treated, CB7630 was well tolerated with only minimal toxicity in this post-docetaxel population. In the 21 patients who have been in the study for over 3 months, 10 patients (48%) experienced a confirmed decline in PSA levels of greater than 50% and 2 patients (10%) experienced PSA declines of greater than 90%. Of the 12 evaluable patients with measurable tumor lesions, 2 patients (17%) experienced confirmed partial radiological responses (as measured by the RECIST criteria), 1 patient (8%) experienced an unconfirmed partial response and 5 patients experienced ongoing stable disease (including one patient with a minor response). Individual patients treated with CB7630 also experienced improvement in pain and a reduction in opioid use. Twenty-eight of the 43 patients (65%) enrolled in this trial are still receiving treatment with CB7630.

Dr. Arie S. Belldegrun, M.D., FACS, Vice Chairman of the Board of Directors of Cougar Biotechnology, said, "The data on CB7630 presented at the ESMO Conference is important for several reasons. First, not only does it confirm the earlier signal of clinical activity in second line hormonal therapy patients, but it also for the first time demonstrates that CB7630 is capable of impacting time to progression in patients with metastatic disease. The time to progression data presented in the CB7630 trial compares favorably to that which has been reported for other currently used second line hormonal therapies. Second, the data provides additional confirmation of CB7630's activity in second line chemotherapy patients. As both
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
3. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
4. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
7. Prana Biotechnology Presents New Key Findings on PBT2
8. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
(Date:6/30/2015)... Long Beach, CA (PRWEB) , ... June 30, 2015 , ... ... Sea Skilled Nursing”, which features multiple patient and family member testimonials. Medicare rated the ... the country. Broadway plans to use the video to give future patients a firsthand ...
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of ... multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, ... to the Court’s calendar, that conference has now been scheduled for July 9th, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Allied Anesthesia ... Allied’s Fullerton division volunteered to help provide free outpatient procedures to some of ... at St. Jude Medical Center. , The event was coordinated by AccessOC, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Red Hot & Blue Restaurants, Inc. ... poll at http://scoutology.com/novaburgerwars and was selected as “Best BBQ” in a Texas-based ... , Red Hot & Blue President Randy McCann said, “Everyone knows Red Hot & ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... New Energy ... York July 7th and 11th 2015. Timber frame post and beam raisings offer a ... , “Raising a timber frame is an important and exciting event – ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4
... Meeting, Obesity 2009, in Washington DC, October 24-28 and ... SILVER SPRING, Md., Feb. 6 This week, The ... to the study of obesity, opened its 2009 call ... scientific meeting, which will be held in Washington, DC, ...
... Calif., Feb. 6 Masimo Corporation (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, today announced that its ... Partners 21st Annual OC Growth Stock Conference at The ... February 18, 2009, at 11:00 a.m. PT. A live ...
... -- Underwriters Laboratories is notifying consumers, sign installers, ... Redwood Sign bear a counterfeit UL Mark. Redwood Sign ... its signs, or represent that its products are UL-LISTED. ... UL and are not authorized to bear the UL ...
... management experts representing the American Pain Society (APS) ... has published the first comprehensive, evidence-based clinical practice ... pain medications for patients with chronic non-cancer pain. ... of The Journal of Pain , ...
... family history of Alzheimer’s disease, who have high levels of amyloid ... disease. , ... Manhasset, NY (Vocus) February 6, 2009 ... high levels of amyloid beta (A²) in the serum, are at ...
... 6 "Psoriasis Cure Now," a nonprofit patient advocacy ... to help everyday Americans interested in medical research be ... by powerful lobbyists and special interests. The Web ... to make biomedical research a meaningful part of any ...
Cached Medicine News:Health News:Obesity Society Announces 2009 Call for Abstracts 2Health News:Obesity Society Announces 2009 Call for Abstracts 3Health News:Masimo to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference 2Health News:UL Warns of Counterfeit Electric Signs 2Health News:New guideline for prescribing opioid pain drugs published 2Health News:New guideline for prescribing opioid pain drugs published 3Health News:Amyloid Beta Level in Serum Predicts Risk for Vascular Disease in First-Degree Relatives of Alzheimer's Patients 2Health News:Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: